Clinical trials
Completed Colorectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,736 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 36 |
| 2001 | 47 |
| 2002 | 46 |
| 2003 | 69 |
| 2004 | 70 |
| 2005 | 92 |
| 2006 | 102 |
| 2007 | 114 |
| 2008 | 115 |
| 2009 | 121 |
| 2010 | 132 |
| 2011 | 124 |
| 2012 | 150 |
| 2013 | 116 |
| 2014 | 127 |
| 2015 | 121 |
| 2016 | 126 |
| 2017 | 133 |
| 2018 | 142 |
| 2019 | 117 |
| 2020 | 123 |
| 2021 | 123 |
| 2022 | 106 |
| 2023 | 85 |
| 2024 | 52 |
| 2025 | 25 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,736 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 67 |
| Memorial Sloan Kettering Cancer Center | 48 |
| National Cancer Institute (NCI) | 43 |
| M.D. Anderson Cancer Center | 36 |
| Amgen | 35 |
| Alliance for Clinical Trials in Oncology | 33 |
| Bayer | 28 |
| Eli Lilly and Company | 25 |
| Pfizer | 24 |
| Genentech, Inc. | 21 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 2,736 |
| Colonic Neoplasms | 488 |
| Rectal Neoplasms | 383 |
| Breast Neoplasms | 246 |
| Neoplasms | 199 |
| Neoplasm Metastasis | 191 |
| Pancreatic Neoplasms | 168 |
| Lung Neoplasms | 147 |
| Carcinoma, Non-Small-Cell Lung | 146 |
| Ovarian Neoplasms | 124 |
Trials
Showing 51 to 75 of 2,736. Each trial links to its page on Pharma Observatory.
2,636 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.